Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

791 projects found matching your search criteria :

  1. Integrative analysis of tRNA modification circuits and aminoacylation and their role in breast cancer model.

    Call: OPUS 29 , Panel: NZ2

    Principal investigator: dr Marcin Sajek

    Instytut Genetyki Człowieka PAN

  2. ECLECTIC: Endometrial Cancer multiLayered Evaluation of Clinico-Metabo-Histo-Molecular data for Translational Integrativ...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Julia Zelkowska

    Uniwersytet Medyczny w Białymstoku

  3. Proteomic characterization, transcriptional and epigenetic regulation of drugtransporters in colorectal cancer

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Nina Ewa Komaniecka

    Pomorski Uniwersytet Medyczny w Szczecinie

  4. Molecular pathways involved in nuclear membrane stress adaptation and its role in breast and prostate cancer

    Call: OPUS 29 , Panel: NZ3

    Principal investigator: dr Paulina Nastały

    Gdański Uniwersytet Medyczny

  5. M. bovis BCG extracellular vesicles as an alternative in bladder cancer immunotherapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Jakub Smoliński

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  6. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  7. Development of Red-Emitting Chiral Carbon Dots for Advanced Photodynamic Therapy (PDT)

    Call: PRELUDIUM 24 , Panel: ST8

    Principal investigator: Patryk Szymaszek

    Politechnika Krakowska im. Tadeusza Kościuszki

  8. Development of the fluorescence multifunctional biosensing system based on antisense oligonucleotide probes for the onco...

    Call: PRELUDIUM 24 , Panel: ST4

    Principal investigator: Hubert Grzegorz Grel

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  9. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

  10. Metabolic biomarkers of prostate cancer

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Tomasz Łukasz Ruman

    Politechnika Rzeszowska im. Ignacego Łukasiewicza

  11. LLT1 as a regulator of the immune response and a dual-target immunotherapy approach in colorectal cancer directed at NK ...

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr Marzena Dorota Lenart

    Uniwersytet Jagielloński

  12. "The Role of Adipose Tissue and microRNA in the Progression of Clear Cell RenalCell Carcinoma".

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Dorota Małgorzata Kwapisz

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  13. Rola TRIM32 i TRIM34 w regulacji metabolizmu guza i mikrośrodowiska immunologicznego w raku jajnika

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Alicja Katarzyna Rajtak

    Uniwersytet Medyczny w Lublinie

  14. We are Left Without Oxygen—Now What?: Evaluation of Hypoxia-Inducible COL Family Genes in Glioblastoma Patients and Thei...

    Call: OPUS 29 , Panel: NZ4

    Principal investigator: prof. Ewa Izabela Balcerczak

    Uniwersytet Medyczny w Łodzi

  15. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Joanna Irena Szechyńska

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  16. Intestinal barrier dysfunction as a risk factor for pancreatic ductal adenocarcinoma: impact of fatty acid intake, with ...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Wojciech Michał Jankowski

    Uniwersytet Medyczny w Łodzi

  17. New violacein derivatives as candidates for sonodynamic therapy against skin cancer

    Call: SONATINA 9 , Panel: NZ7

    Principal investigator: dr Daniel Ryszard Ziental

    Uniwersytet Przyrodniczy w Poznaniu

  18. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  19. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr hab. Ewelina Piktel

    Uniwersytet Medyczny w Białymstoku

  20. Reciprocal relationships in metastatic colorectal cancer and its niche – from adaptation to host organs to induced paren...

    Call: OPUS 28 (LAP) , Panel: NZ2

    Principal investigator: dr Michał Artur Bieńkowski

    Gdański Uniwersytet Medyczny

  21. Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Ewelina Wioletta Lipiec

    Uniwersytet Jagielloński

  22. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  23. New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  24. Targeting Telomere Integrity as an Approach to Eradicate Cancer Cells

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Natalia Anna Maciejewska

    Politechnika Gdańska

  25. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  26. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  27. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  28. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  29. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap...

    Call: OPUS 28 , Panel: NZ3

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

  30. Aptamer-mediated SERS/DEP Biosensors for proteomic analysis of extracellular vesicles of salivary gland tumors: towards ...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Agnieszka Edyta Michota-Kamińska

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  31. Harnessing NK cells and Graphene Oxide Nanoparticles for Pancreatic Ductal Adenocarcinoma Immunotherapy

    Call: OPUS 28 (LAP) , Panel: NZ7

    Principal investigator: prof. Iwona Maria Inkielewicz-Stępniak

    Gdański Uniwersytet Medyczny

  32. Canonical and non-canonical roles of DDK in oncogenesis: a cornerstone for the development of novel, potent anticancer t...

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Jan Marian Suski

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  33. Supramolecular nanoparticles able to block calcium channels in cancer cells

    Call: SONATA BIS 14 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

  34. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  35. Molecular factors and pathomechanism of cancer-associated cachexia.

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Marcin Tomasz Skrzypski

    Gdański Uniwersytet Medyczny

  36. ERβ-mediated autophagy in colorectal cancer and its impact on carcinogenesis

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Julia Maria Lipowicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  37. Biomaterial enriched with propolis extract as a promising chemopreventive dressing material after melanoma excision

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Marta Trzaskowska

    Uniwersytet Medyczny w Lublinie

  38. Profiling of the stroma by spatial transcriptomics in aid of prognostication in FGFR2-mediated luminal breast cancer

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Julia Maria Sołek-Siejka

    Uniwersytet Medyczny w Łodzi

  39. Cellular effects in the tumor microenvironment and the potential for targeted delivery of molecules associated with the ...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: prof. Magdalena Maria Staniszewska

    Katolicki Uniwersytet Lubelski Jana Pawła II

  40. Frog skin derived cyclic peptide as a molecular scaffold to create a novel tool for combining visualization and inhibiti...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Aleksandra Dorota Helbik-Maciejewska

    Uniwersytet Gdański

  41. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  42. (Lipid-FLUX) Single-cell lipidomics by spectroscopy: Quantification of the lipid transport through the development of ne...

    Call: OPUS 27 , Panel: ST4

    Principal investigator: prof. Małgorzata Anna Barańska

    Uniwersytet Jagielloński

  43. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    UNIWERSYTET ŚLĄSKI

  44. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Katarzyna Anna Malarz

    Politechnika Śląska

  45. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  46. Controlling the covalent activity of a PD-L1 inhibitors with light

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

  47. EGR1 Protein: A Key Factor in Cellular Homeostasis?

    Call: PRELUDIUM 23 , Panel: NZ3

    Principal investigator: Marta Leśniczak-Staszak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  48. Metastasis process regulation by inhibiting neutrophils NETosis through phytocannabinoids and the endocannabinoid system

    Call: PRELUDIUM 23 , Panel: NZ1

    Principal investigator: Izabela Marianna Krauze

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  49. Proteomic predictors of metastasis in colorectal cancer – a validation study

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Anna Wojakowska

    Instytut Chemii Bioorganicznej PAN

  50. Is organ-on-a-chip technology able to reduce animal sacrifice in studies on radiosensitizers?

    Call: OPUS 27 , Panel: ST4

    Principal investigator: prof. Janusz Adam Rak

    Uniwersytet Gdański

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy